| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 141,100 | 110,000 | | Cost of Revenue | 33,600 | 27,000 | | | Gross Profit | 107,500 | 83,000 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 4,300 | 4,000 | | Non Recurring |
-
|
-
| | Others | 26,100 | 16,000 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 77,100 | 63,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,500 | 7,000 | | Earnings Before Interest And Taxes | 137,400 | 75,000 | | Interest Expense | 22,900 | 9,000 | | Income Before Tax | 114,500 | 66,000 | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 114,500 | 66,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 114,500 | 66,000 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $114,500 | $66,000 |
|
1.23% Nasdaq 
Income Statement
